Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.843345
Abstract: Since osteosarcoma (OS) is an aggressive bone cancer with unknown molecular pathways of etiology and pathophysiology, improving patient survival has long been a challenge. The conventional therapy is a complex multidisciplinary management that include radiotherapy,…
read more here.
Keywords:
delivery chemotherapeutic;
agents osteosarcoma;
targeted delivery;
chemotherapeutic agents ... See more keywords